Risk factors for intracranial aneurysm rupture in pediatric patients

Ruiqi Chen1, Si Zhang1, Anqi Xiao1

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, Sichuan, China.

Acta Neurochirurgica
|August 20, 2021
PubMed

Insights

Pediatric intracranial aneurysms (IAs) pose a fatal risk. Children under 5 and IAs in the distal arterial region (DAR) are key rupture risk factors, while wide-necked IAs offer protection.

Area of Science:

  • Neurology
  • Pediatric Medicine
  • Vascular Surgery

Background:

  • Intracranial aneurysms (IAs) are rare but fatal in children.
  • Risk factors for IA rupture in adults are known, but unknown in pediatric patients.

Purpose of the Study:

  • To identify risk factors for intracranial aneurysm rupture in pediatric patients.
  • To elucidate the characteristics of pediatric intracranial aneurysms associated with rupture.

Main Methods:

  • Retrospective analysis of 94 pediatric patients with intracranial aneurysms.
  • Division of patients into ruptured and unruptured groups.
  • Univariable and multiple logistic regression analyses to identify risk factors.

Main Results:

  • Age under 5 years (OR=6.844, P=0.042) and location in the distal arterial region (DAR) (OR=4.162, P=0.029) were independent risk factors for rupture.
  • Wide-necked aneurysms (OR=0.235, P=0.047) were independently associated with a lower risk of rupture.
  • Giant aneurysms and those in the internal carotid artery were more common in the unruptured group.

Conclusions:

  • Younger age (0-5 years) and distal arterial region (DAR) location are independent risk factors for pediatric intracranial aneurysm rupture.
  • Wide-necked intracranial aneurysms are associated with a reduced risk of rupture in pediatric patients.
  • Findings aid in risk stratification and management of pediatric intracranial aneurysms.
Abstract

Related Concept Videos

Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
78
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
57
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
55
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
56
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
56
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39